ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_upward
+1.04%(+0.0050) 1D
Nov 17, 12:05:33 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.49
High
A$0.49
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
265.00K
Volume
253.60K
P/E ratio
46.28
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.49
High
A$0.49
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
265.00K
Volume
253.60K
P/E ratio
46.28
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
Stocktwits
·
1 hour ago
S&P 500, Dow, Nasdaq End Lower As Investors Hold Back Ahead Of Nvidia Earnings, Anthropic IPO This Week — NVDA, TSLA, ANT In Focus
ChartMill
·
5 hours ago
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
BigGo Finance
·
11 hours ago
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
www.tokenpost.com
·
49 minutes ago
Nasdaq Composite Falls 2.49% as Tempus AI Leads AI Stock Declines
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd